From: Coffee consumption and NAFLD: a community based study on 1223 subjects
Hepatic steatosis not diagnosed (n = 1071, mean ± STD) | Hepatic steatosis diagnosed (n = 381, mean ± STD) | Total | p value | |
---|---|---|---|---|
Gender, n (%) | ||||
Female | 639 (59.7 %) | 150 (39.4 %) | 789 (54.3 %) | <0.0001 |
Male | 432 (40.3 %) | 231 (60.6 %) | 663 (45.7 %) | |
Age | 39.9 ± 12.4 | 49.0 ± 11.4 | 42.3 ± 12.8 | <0.0001 |
BMI | 24.1 ± 3.8 | 29.8 ± 4.7 | 25.6 ± 4.7 | <0.0001 |
Waist/hip-ratio | 0.8 ± 0.1 | 0.9 ± 0.1 | 0.8 ± 0.1 | <0.0001 |
Coffee consumption, n (%) | ||||
More than once a day | 209 (19.5 %) | 72 (18.9 %) | 281 (19.4 %) | |
Daily | 587 (54.8 %) | 237 (62.2 %) | 824 (56.8 %) | |
Less than weekly | 86 (8.0 %) | 26 (6.8 %) | 112 (7.7 %) | |
Less than monthly | 45 (4.2 %) | 7 (1.8 %) | 52 (3.6 %) | 0.0408 |
Seldom/rarely | 144 (13.5 %) | 39 (10.2 %) | 183 (12.6 %) | |
ALT | 13.3 ± 5.6 | 20.0 ± 10.6 | 15.1 ± 7.8 | <0.0001 |
AST | 8.9 ± 2.4 | 11.0 ± 5.1 | 9.5 ± 3.5 | <0.0001 |
GGT | 11.0 ± 11.0 | 19.1 ± 20.3 | 13.2 ± 14.5 | <0.0001 |
Metabolic syndrome, n (%) | ||||
No | 1050 (98.0 %) | 317 (83.2 %) | 1367 (94.2 %) | <0.0001 |
Yes | 21 (2.0 %) | 64 (16.8 %) | 85 (5.9 %) |